Luigi Mangione confessed in court last Friday to the fatal shooting of health insurance executive Brian Thompson and pleaded guilty to two federal charges of stalking the CEO with the intent to kill him.
During the court proceedings, Mangione, dressed in beige prison attire, acknowledged his actions by stating, “I shot Mr. Thompson in Manhattan, and he died.” He delivered his statement calmly, criticizing the U.S. health insurance system.
In attendance was Thompson’s widow, who sat in the front row alongside other family members. Her emotions surfaced as Mangione admitted to the shooting, prompting support from those seated beside her.
The guilty plea effectively avoids a federal trial in the high-profile case involving the killing of the 50-year-old UnitedHealthcare CEO. This brazen act, condemned by public figures, became symbolic of the American public’s discontent with health insurance industry practices.
Mangione, aged 28, entered his plea without a negotiated agreement with federal prosecutors, leaving no assurance of leniency during sentencing scheduled for December 18. Prosecutors are seeking the maximum penalty of life imprisonment.
U.S. District Judge Margaret Garnett may consider Mangione’s guilty plea as a mitigating factor in determining his punishment. Additionally, the federal plea enables Mangione’s legal team to file a motion to dismiss separate state charges of murder and weapons possession, citing New York’s prohibition of double jeopardy.
Manhattan U.S. Attorney Jamie McDonald emphasized that no concessions were made to Mangione by his office. McDonald firmly stated, “No grievance or ideological cause can ever justify murder,” reflecting on the severity of the crime.
Thompson’s family expressed that the plea represents a crucial step towards justice and urged the court to ensure that the sentencing aligns with the gravity of the offense.
Before the fatal incident on December 4, 2024, Thompson led the insurance division of Minnesota-based UnitedHealth Group. The graphic nature of the killing and the subsequent manhunt for the suspect garnered significant media attention and social media engagement, ultimately leading to Mangione’s arrest in Pennsylvania.
Mangione disclosed in court that he faced challenges with his insurance after sustaining a broken back, without elaborating. His elaborate plan included posing as an investor managing substantial assets to gain access to information about the investor conference where he intended to carry out the attack.
UnitedHealth Group expressed gratitude to law enforcement for apprehending Thompson’s killer, emphasizing the closure brought by Mangione’s admission of guilt.
Mangione’s previous plea of not guilty to federal charges in April 2025 was followed by the dismissal of murder and weapons charges in January 2026 due to legal technicalities. Separate state charges, including terrorism, murder, weapons possession, and forgery, are pending trial in Manhattan.
The defence argued for the dismissal of the state case under New York’s double jeopardy law, citing violations of Mangione’s constitutional rights. State prosecutors may face challenges in pursuing the case due to overlapping elements of the stalking charges and murder intent.
Legal experts speculate on the complexities of the case, with the defence emphasizing the overlap in intent between the charges, while prosecutors may argue for distinct elements. The trial is set for September 8 before Justice Gregory Carro in Manhattan, with potential implications on Mangione’s fate.